2m 2m 2m 2m 2m 2m 2m
OLEMA PHARMA (OLMA)
NASDAQ
$8.23-$0.04 (-0.48%)
Price as of Oct 02, 2026 5:30 PM EDT- $723.6MMarket Cap
- -25.76%1-Year Change
- BiotechnologyIndustry
OLEMA PHARMA (OLMA)
$8.23-$0.04 (-0.48%)
OLMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.27 | ||
Change | -$0.37 (-4.28%) | ||
Open | $8.58 | ||
High | $8.66 | ||
Low | $8.19 | ||
Previous Close | $8.64 | ||
Volume | 1,009,506 | ||
30-Day Average Volume | 1,239,935 | ||
1-Week Change | -8.52% | ||
1-Month Change | -21.69% | ||
1-Year Change | -25.76% | ||
3-Year Change | -33.04% | ||
5-Year Change | -71.58% | ||
Fundamentals | |||
Shares Outstanding | 87.5M | ||
Total Assets | $486.6M | ||
Market Cap | $723.6M | ||
Enterprise Value | $678.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$63.2M | ||
Free Cash Flow | -$45.9M | ||
EBIT | -$63.2M | ||
EBITDA | -$63.1M | ||
Net Working Capital | $416.9M | ||
EPS | -$0.61 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -14 | ||
PEG | 1 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue